Emedastine

Emedastine

SCHEMBL449581

CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21.O=C(O)C=CC(=O)O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HRH1

The experimentally established mechanism targets of Emedastine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Emedastine SCHEMBL449580 1.00 POLB (0.62) POLB
Emedastine SCHEMBL29846167 1.00 POLB (0.62) POLB
Emedastine SCHEMBL41384 1.00 POLB (0.62) POLB
Emedastine SCHEMBL41386 1.00 POLB (0.62) POLB
Emedastine SCHEMBL1649085 1.00 POLB (0.62) POLB
Emedastine SCHEMBL41385 1.00 POLB (0.62) POLB
Fumaric Acid SCHEMBL10920208 0.93 POLB (0.63) POLB
Fumaric Acid SCHEMBL10920204 0.93 POLB (0.63) POLB
Emedastine SCHEMBL29770 0.91
Emedastine SCHEMBL29493445 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 463 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122031382-A Emerastine fumarate eye drops and preparation method thereof 江苏远恒药业有限公司 2026-05-15 CN claimed
CN-120131543-A Emerastine fumarate eye drops and preparation method thereof 石家庄四药有限公司 2025-06-13 CN claimed
CN-119139256-B Emedastine fumarate preparation and preparation method thereof 安徽瑞旗药业有限公司 2025-05-27 CN claimed
CN-119241510-A Preparation method of emedastine fumarate 南京唯创远医药科技有限公司 2025-01-03 CN claimed
CN-119139256-A Emedastine fumarate preparation and preparation method thereof 安徽瑞旗药业有限公司 2024-12-17 CN claimed
CN-118903147-A Emedastine fumarate composition and preparation method thereof 湖南普道医药技术有限公司 2024-11-08 CN claimed
CN-118812440-A Method for continuously preparing intermediate 1- (2-ethoxyethyl) -2- (4-methyl-1, 4-homopiperazin-1-yl) -1H- [ d ] -benzimidazole 南京恒道医药科技股份有限公司 2024-10-22 CN claimed
CN-118557551-A Emerastine fumarate sustained-release capsule and preparation method thereof 四川德峰药业有限公司 2024-08-30 CN claimed
CN-107735401-B Substituted dihydropyrrolopyrazole derivatives 宇部兴产株式会社 2021-08-31 CN claimed
CN-107875119-B Emedastine fumarate aqueous pharmaceutical composition and preparation method thereof 山东绅联药业有限公司 2021-03-12 CN claimed
EP-2043613-A1 SOLID FORM FMC CORPORATION (US) 2009-04-08 EP claimed
US-20080311162-A1 Solid form FMC CORPORATION 2008-12-18 US claimed
US-20080286343-A1 Solid form FMC CORPORATION 2008-11-20 US claimed
WO-2008140460-A1 SOLID FORM FMC CORPORATION (US) 2008-11-20 WO claimed
WO-2008140461-A1 SOLID FORM FMC CORPORATION (US) 2008-11-20 WO claimed
US-20080286344-A1 Solid form FMC CORPORATION 2008-11-20 US claimed
WO-2008008120-A1 SOLID FORM FMC CORPORATION (US) 2008-01-17 WO claimed
US-20080014228-A1 Solid form FMC CORPORATION 2008-01-17 US claimed
CN-1658888-A Quaternised ammonium cyclodextrin compounds NOVARTIS AG (CH) 2005-08-24 CN claimed
CN-1483478-A Eye preparation formula adapted for therapentic medicine 无锡杰西医药科技有限公司 2004-03-24 CN claimed